These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Predominant and novel de novo variants in 29 individuals with ALG13 deficiency: Clinical description, biomarker status, biochemical analysis, and treatment suggestions. Ng BG, Eklund EA, Shiryaev SA, Dong YY, Abbott MA, Asteggiano C, Bamshad MJ, Barr E, Bernstein JA, Chelakkadan S, Christodoulou J, Chung WK, Ciliberto MA, Cousin J, Gardiner F, Ghosh S, Graf WD, Grunewald S, Hammond K, Hauser NS, Hoganson GE, Houck KM, Kohler JN, Morava E, Larson AA, Liu P, Madathil S, McCormack C, Meeks NJL, Miller R, Monaghan KG, Nickerson DA, Palculict TB, Papazoglu GM, Pletcher BA, Scheffer IE, Schenone AB, Schnur RE, Si Y, Rowe LJ, Serrano Russi AH, Russo RS, Thabet F, Tuite A, Villanueva MM, Wang RY, Webster RI, Wilson D, Zalan A, Undiagnosed Diseases Network, University of Washington Center for Mendelian Genomics (UW-CMG), Wolfe LA, Rosenfeld JA, Rhodes L, Freeze HH. J Inherit Metab Dis; 2020 Nov; 43(6):1333-1348. PubMed ID: 32681751 [Abstract] [Full Text] [Related]
4. The phenotype and treatment of SCN2A-related developmental and epileptic encephalopathy. Kim HJ, Yang D, Kim SH, Kim B, Kim HD, Lee JS, Choi JR, Lee ST, Kang HC. Epileptic Disord; 2020 Oct 01; 22(5):563-570. PubMed ID: 33000761 [Abstract] [Full Text] [Related]
15. ALG13-Congenital Disorder of Glycosylation (ALG13-CDG): Updated clinical and molecular review and clinical management guidelines. Shah R, Eklund EA, Radenkovic S, Sadek M, Shammas I, Verberkmoes S, Ng BG, Freeze HH, Edmondson AC, He M, Kozicz T, Altassan R, Morava E. Mol Genet Metab; 2024 Jun 01; 142(2):108472. PubMed ID: 38703411 [Abstract] [Full Text] [Related]
16. Targeted gene panel sequencing in early infantile onset developmental and epileptic encephalopathy. Na JH, Shin S, Yang D, Kim B, Kim HD, Kim S, Lee JS, Choi JR, Lee ST, Kang HC. Brain Dev; 2020 Jun 01; 42(6):438-448. PubMed ID: 32139178 [Abstract] [Full Text] [Related]
17. ATN1-related infantile developmental and epileptic encephalopathy responding to Ketogenic diet. Xie Y, Su T, Liu Y, Xu S. Seizure; 2024 Apr 01; 117():1-5. PubMed ID: 38262122 [Abstract] [Full Text] [Related]
18. Severe infantile onset developmental and epileptic encephalopathy caused by mutations in autophagy gene WDR45. Carvill GL, Liu A, Mandelstam S, Schneider A, Lacroix A, Zemel M, McMahon JM, Bello-Espinosa L, Mackay M, Wallace G, Waak M, Zhang J, Yang X, Malone S, Zhang YH, Mefford HC, Scheffer IE. Epilepsia; 2018 Jan 01; 59(1):e5-e13. PubMed ID: 29171013 [Abstract] [Full Text] [Related]
19. Phenotypic spectrum of GNAO1 variants: epileptic encephalopathy to involuntary movements with severe developmental delay. Saitsu H, Fukai R, Ben-Zeev B, Sakai Y, Mimaki M, Okamoto N, Suzuki Y, Monden Y, Saito H, Tziperman B, Torio M, Akamine S, Takahashi N, Osaka H, Yamagata T, Nakamura K, Tsurusaki Y, Nakashima M, Miyake N, Shiina M, Ogata K, Matsumoto N. Eur J Hum Genet; 2016 Jan 01; 24(1):129-34. PubMed ID: 25966631 [Abstract] [Full Text] [Related]
20. Clinical manifestations and epilepsy treatment in Japanese patients with pathogenic CDKL5 variants. Kobayashi Y, Tohyama J, Takahashi Y, Goto T, Haginoya K, Inoue T, Kubota M, Fujita H, Honda R, Ito M, Kishimoto K, Nakamura K, Sakai Y, Takanashi JI, Tanaka M, Tanda K, Tominaga K, Yoshioka S, Kato M, Nakashima M, Saitsu H, Matsumoto N. Brain Dev; 2021 Apr 01; 43(4):505-514. PubMed ID: 33436160 [Abstract] [Full Text] [Related] Page: [Next] [New Search]